• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
Progesterone Treatmant Enhances The Expansion Of Placental Immature Myeloid Cells In A Mouse Model Of Premature Labor
Home ‹ 2010 Abstracts ‹ Progesterone Treatmant Enhances The Expansion Of Placental Immature Myeloid Cells In A Mouse Model Of Premature Labor

Ola Gutzeit, Rivka Hertz, Yuval Ginsberg, Ron Beloosesky, Zeev Weiner, Ofer Fainaru

Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel 

Objective: Immature myeloid cells (IMCs) are bone marrow-derived cells that normally differentiate into granulocytes, macrophages, and dendritic cells (DCs) but expand in pathological conditions. We have previously shown that IMCs accumulate in placentas, promote angiogenesis, peak during mid-pregnancy and correlate with neonatal birthweight. Progesterone has been shown to inhibit prmature labor and delivery. We thus hypothesized that progesterone may affect the placental IMC population.

Study Design: Mice bone marrow (BM) cells selected for CD11b+ expression by magnetic separation (MACS) were incubated for 5 days with/without progesterone. Myeloid cells were defined as Ly6Gmed/Ly6Chigh “monoctyic”- or Ly6Ghigh/Ly6Cmed “granulocytic” IMCs by flow cytometry. Mosue preterm labor model: ICR pregnant mice (n=29) were pretreated with/without vaginal progesterone (1mg/day) or carrier (Replens) from 13E-16E. Lipopolysaccharide(LPS) (30µg)/vehicle was administered intrapertioneally at 15E-16E. Next, mice were sacrificed, BM and placental cells were immunostained and analyzed by flow cytometry.

Results: In culture, progesterone treated BM-IMCs demonstrated a significant monocytic-IMCs population decrease and a granulocytic-IMC population increase. The DC population decreased in the presence of progesterone.   In mice, LPS treatment led to an increase in IMCs populating the BM in both P-pretreated (41.5±9.5vs.1.3±0.3%,p=0.05) or non-pretreated mice (20.8±9.4vs.1.3±0.6%,p=0.05). In the placenta, LPS led to a decline in IMCs. Strikingly, progesterone pretreatment led to complete abrogation of this effect (control:28.2±6.1; P:29.6±4.7; LPS:23.0±2.6; P+LPS:35.4±2.5%; p=0.01).

Conclusion: Progesterone enhances the proliferation of bone marrow derived IMCs in vitro.  In mice, LPS leads to a decrease in placental IMCs. This effect was completely abrogated in progesterone pretreated mice. We thus speculate that the protective effect of progesterone in preventing preterm labor may be explained at least in part by this specific anti-inflammatory effect.

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top